Cargando…
4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells
OBJECTIVES: Pancreatic ductal adenocarcinoma contains large amounts of the glycosaminoglycan hyaluronan (HA), which is involved in various physiological processes. Here, we aimed to clarify the anticancer mechanisms of 4-methylumbelliferone (MU), a well-known HA synthesis inhibitor. METHODS: MIA PaC...
Autores principales: | Nagase, Hayato, Kudo, Daisuke, Suto, Akiko, Yoshida, Eri, Suto, Shinichiro, Negishi, Mika, Kakizaki, Ikuko, Hakamada, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266424/ https://www.ncbi.nlm.nih.gov/pubmed/27846148 http://dx.doi.org/10.1097/MPA.0000000000000741 |
Ejemplares similares
-
Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer
por: Yoshida, Eri, et al.
Publicado: (2016) -
The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
por: Kudo, Daisuke, et al.
Publicado: (2017) -
Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts
por: Galgoczi, Erika, et al.
Publicado: (2020) -
Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation
por: Steen, Emily H., et al.
Publicado: (2021) -
4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
por: Nagy, Nadine, et al.
Publicado: (2015)